ITRM 10-Q Quarterly Report Sept. 30, 2024 | Alphaminr
Iterum Therapeutics plc

ITRM 10-Q Quarter ended Sept. 30, 2024

ITERUM THERAPEUTICS PLC
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
CIK: 1659323
Filing Type: DEFA14A
Report Date: 2024-09-30
Download URL: https://www.sec.gov/Archives/edgar/data/1659323/000095017024110169/itrm-20240930.htm
]]>
TABLE OF CONTENTS
Part I FinanciItem 1. Financial Statements (unaudited)Item 1. FinanciItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 2. Management S Discussion and Analysis OfItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 3. Quantitative and QualitatiItem 4. Controls and ProceduresItem 4. ControlsPart II Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 5. Other InformationItem 6. Exhibits

Exhibits

4.1 Form of 1-Year Warrant to Subscribe for Ordinary Shares Form S1/A (Exhibit 4.15) July 17, 2024 333-280045 4.2 Form of 5-Year Warrant to Subscribe for Ordinary Shares Form S1/A (Exhibit 4.16) July 17, 2024 333-280045 4.3 Form of 1-Year Warrant Agent Agreement, by and between Iterum Therapeutics plc and Computershare Trust Company, N.A. Form S1/A (Exhibit 4.17) July 17, 2024 333-280045 4.4 Form of 5-Year Warrant Agent Agreement, by and between Iterum Therapeutics plc and Computershare Trust Company, N.A Form S1/A (Exhibit 4.18) July 17, 2024 333-280045 4.5 Form of Rights Certificate Form S1/A (Exhibit 4.19) July 17, 2024 333-280045 10.1 Consulting Agreement dated August 9, 2024 between Iterum Therapeutics International Limited and Dr. Michael W. Dunne 31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.